Impaired glucose regulation appears to correspond with memory decline in aging, and patients with probable Alzheimer's Disease (AD) show particular abnormalities of glucose utilization and regulation. In particular, patients with probable AD show improved memory accompanied by abnormal increases in insulin during hyperglycemia. Preliminary results also show that memory is enhanced for adults with probable AD when plasma insulin levels are raised while plasma glucose is maintained at baseline. These findings suggest that disruption of baseline. These findings suggest that disruption of basic aspects of glucose regulation and utilization may contribute to memory impairment in probable AD. To further examine this hypothesis, four studies are proposed: Study 1 will determine the combined and unique effects of hyperglycemia and hyperinsulinemia on memory performance and glucoregulatory hormone levels in patients with probable AD by examining memory performance during hyperglycemia with basal insulin, during hyperinsulinemia with basal plasma glucose, and when both insulin and glucose raised to predetermined levels; Study 2 will examine dose response curves for glucose in normal elderly adults and adults with probable AD to explore previous findings that hyperglycemic memory facilitation occurs at different plasma glucose levels for some subjects with mild probable AD than for normal elderly; Study 3 will document whether longitudinal changes in glucose regulation are associated with progressive cognitive decline that characterizes probable AD as has been suggested by previous findings that changes in insulin and cortisol levels are closely associated with the progression of dementia; Study 4 will examine dose response curves for 4 different insulin infusion rates to investigate the effects of different insulin levels on memory performance in patients with probable AD and healthy elderly adults. The results of these studies will provide important information about mechanisms disrupting glucose regulation in probable AD, and about the role these mechanisms play in the cognitive deficits that characterize the disorder.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
5R01AG010880-06
Application #
2683134
Study Section
Human Development and Aging Subcommittee 3 (HUD)
Project Start
1992-09-10
Project End
2000-03-31
Budget Start
1998-04-01
Budget End
1999-03-31
Support Year
6
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Washington
Department
Psychiatry
Type
Schools of Medicine
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195
Cholerton, Brenna; Baker, Laura D; Craft, Suzanne (2013) Insulin, cognition, and dementia. Eur J Pharmacol 719:170-9
Baker, Laura D; Bayer-Carter, Jennifer L; Skinner, Jeannine et al. (2012) High-intensity physical activity modulates diet effects on cerebrospinal amyloid-? levels in normal aging and mild cognitive impairment. J Alzheimers Dis 28:137-46
Cudaback, Eiron; Li, Xianwu; Yang, Yue et al. (2012) Apolipoprotein C-I is an APOE genotype-dependent suppressor of glial activation. J Neuroinflammation 9:192
Sonnen, J A; Larson, E B; Walker, R L et al. (2010) Nonsteroidal anti-inflammatory drugs are associated with increased neuritic plaques. Neurology 75:1203-10
Craft, Suzanne (2007) Insulin resistance and Alzheimer's disease pathogenesis: potential mechanisms and implications for treatment. Curr Alzheimer Res 4:147-52
Watson, G Stennis; Craft, Suzanne (2006) Insulin resistance, inflammation, and cognition in Alzheimer's Disease: lessons for multiple sclerosis. J Neurol Sci 245:21-33
Kulstad, J J; Green, P S; Cook, D G et al. (2006) Differential modulation of plasma beta-amyloid by insulin in patients with Alzheimer disease. Neurology 66:1506-10
Pedersen, Ward A; McMillan, Pamela J; Kulstad, J Jacob et al. (2006) Rosiglitazone attenuates learning and memory deficits in Tg2576 Alzheimer mice. Exp Neurol 199:265-73
Watson, G Stennis; Bernhardt, Tanja; Reger, Mark A et al. (2006) Insulin effects on CSF norepinephrine and cognition in Alzheimer's disease. Neurobiol Aging 27:38-41
Craft, Suzanne (2006) Insulin resistance syndrome and Alzheimer disease: pathophysiologic mechanisms and therapeutic implications. Alzheimer Dis Assoc Disord 20:298-301

Showing the most recent 10 out of 23 publications